These findings emphasize how a more restricted TME (under the skin) allows for the generation of significant antitumoral responses by the increased immunogenicity of the ID8-p53−/−NLRC5+ cells, similar to that previously observed with the B16-F10 melanoma model (20). Here, TP53 is linked to melanoma.